Figure 4From: Expression of the dopaminergic D1 and D2 receptors in the anterior cingulate cortex in a model of neuropathic pain Immuno Dot performed for D1R in control animals in the cerebral cortex. This control was done in order to validate the experimental procedure for dopamine D1 receptors in the ACC and the specificity of the antibody. The (A) column shows the blocking D1R peptide without primary antibody, (B) shows the blocking D1R peptide with D1R antibody and (C) the result in the cerebral cortex of control animals. The concentrations shown are the ones with positivity; the results were negative from 10-3.Back to article page